With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and o...
A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed o...
Festus Mogae, Former Botswana President Who Tackled H.I.V., Dies at 86
He led the southern African nation for a decade and embraced a flagship American aid program credited with helping to eradicate the country’s AIDS epi...
New PEPFAR Data Show Worrying Declines in Testing and Treatment for H.I.V.
The numbers are the first to quantify the effect of the Trump administration’s shutdown and restarting of a program that has saved millions of lives w...
